TSE:2342 - Trans Genic Inc Trans Genic Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Income Statement Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2008 Q1 2008 Q4 2009 Q1 2009 Q2 2009 Q3 2009 Q4 2010 Q1 2010 Q2 2010 Q3 2010 Q4 2011 Q1 2011 Q3 2012 Q1 2012 Q3 2013 Q1 2013 Q3 2014 Q1 2014 Q3 2015 Q1 2015 Q3 2016 Q1 2016 Q3 2017 Q1 2017 Q3 2018 Q1 2018 Q3 2019 Q1 2019 Q3 2020 Q1 2020 Q3 2021 Q1 Graph
Operating CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 147.69M
-61.2%
152.66M
3.4%
-20.99M
-
-72.97M
-
1.22B
-
Investing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -834.88M
-
-274.75M
-
-318.6M
-
-318.79M
-
48.43M
-
Financing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 193.52M
-77.6%
569.4M
194.2%
666.73M
17.1%
809.87M
21.5%
10.04M
-98.8%
Beginning Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.77B
47.2%
1.33B
-25.2%
1.28B
-3.6%
1.77B
38.5%
1.6B
-9.4%
Effect of FX Change [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -1.31M
-
-2.9M
-
-1.33M
-
88K
-
-493K
-
Changes in Cash [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -493.67M
-
447.32M
-
327.14M
-26.9%
418.11M
27.8%
1.28B
206.3%
End Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.28B
-3.5%
1.77B
38.7%
1.6B
-9.5%
2.19B
36.4%
3.03B
38.5%
Free CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -172.8M
-
-239.17M
-
-277.69M
-
-221.35M
-
1.08B
-
Values are in JPY whenever applicable | Fiscal year ends on March 31
Powered by Morningstar